IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v44y2021i3d10.1007_s40264-020-01024-0.html
   My bibliography  Save this article

Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005–2018

Author

Listed:
  • Masao Iwagami

    (University of Tsukuba
    London School of Hygiene and Tropical Medicine)

  • Ryosuke Kumazawa

    (The University of Tokyo)

  • Yoshihisa Miyamoto

    (The University of Tokyo)

  • Yuri Ito

    (Osaka Medical College)

  • Miho Ishimaru

    (University of Tsukuba)

  • Kojiro Morita

    (University of Tsukuba)

  • Shota Hamada

    (Association for Health Economics Research and Social Insurance and Welfare)

  • Nanako Tamiya

    (University of Tsukuba)

  • Hideo Yasunaga

    (London School of Hygiene and Tropical Medicine)

Abstract

Introduction In September 2019, ranitidine and nizatidine were suggested to contain N-nitrosodimethylamine, a carcinogenic substance. People have since been concerned about the potential impact of ranitidine/nizatidine use on the risk of cancer. Objective The objective of this study was to investigate the risk of cancer among people receiving ranitidine or nizatidine compared with other histamine 2 receptor antagonists (H2 blockers) [cimetidine, famotidine, roxatidine, and lafutidine]. Methods In the Japan Medical Data Center claims database (comprising people aged 730 DDDs. Conclusions We found no evidence that ranitidine/nizatidine is associated with an increased risk of cancer, although further studies with more accurate measurement of exposure, inclusion of older people, and longer follow-up may be needed.

Suggested Citation

  • Masao Iwagami & Ryosuke Kumazawa & Yoshihisa Miyamoto & Yuri Ito & Miho Ishimaru & Kojiro Morita & Shota Hamada & Nanako Tamiya & Hideo Yasunaga, 2021. "Risk of Cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005–2018," Drug Safety, Springer, vol. 44(3), pages 361-371, March.
  • Handle: RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01024-0
    DOI: 10.1007/s40264-020-01024-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-020-01024-0
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-020-01024-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Chun-Hsiang Wang & I-I Chen & Chung-Hung Chen & Yuan-Tsung Tseng, 2022. "Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study," IJERPH, MDPI, vol. 19(19), pages 1-16, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01024-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.